BusinessSouth Korea

Robotis Q3 revenue up 46% to KRW 13.5bn, but it posts a KRW 2.6bn operating loss

Published 4 min read
Source
Robotis Q3 revenue up 46% to KRW 13.5bn, but it posts a KRW 2.6bn operating loss (Illustration by MEKAWIRE)

Robotis reported third-quarter revenue of KRW 13.47bn, up 45.8% from a year earlier, and an operating loss of KRW 2.61bn in the quarterly report it filed on DART on Nov 16. Nine-month revenue of KRW 40.68bn is already above the KRW 38.94bn of all of 2025, while the nine-month operating loss is KRW 12.47bn.

The company booked a KRW 11,781m treasury share grant to employees in the first quarter; without it the nine-month loss would be about KRW 0.69bn (MEKAWIRE calc.). Actuators are 98.1% of sales.

Robotis, the Seoul-based maker of DYNAMIXEL robot actuators, reported third-quarter revenue of KRW 13.47bn, up 45.8% from a year earlier (MEKAWIRE calc.), and an operating loss of KRW 2.61bn against a profit of KRW 224m, according to the quarterly report it filed on DART on Nov 16. Revenue for January to September reached KRW 40.68bn, already above the KRW 38.94bn of the whole of 2025. The nine-month operating loss was KRW 12.47bn, against a profit of KRW 1.29bn a year earlier.

Most of that loss comes from one decision. Robotis said in the report that it completed a grant of treasury shares to employees worth KRW 11,781m on Jan 26 and booked it in first-quarter selling and administrative expenses. Without it the nine-month operating loss would be about KRW 0.69bn (MEKAWIRE calc.). The third quarter carried no such grant and still lost KRW 2.61bn, and that is the figure that says more about 2027.

Costs doubled while the gross margin fell nine points

Robotis consolidated results (KRW bn)
  • Revenue
    Q3 2026
    13.47
    Q3 2025
    9.24
    Nine months 2026
    40.68
    Nine months 2025
    27.34
  • Gross profit
    Q3 2026
    7.08
    Q3 2025
    5.99
    Nine months 2026
    21.80
    Nine months 2025
    17.11
  • Gross margin (MEKAWIRE calc.)
    Q3 2026
    52.6%
    Q3 2025
    64.8%
    Nine months 2026
    53.6%
    Nine months 2025
    62.6%
  • Selling and administrative expenses
    Q3 2026
    9.69
    Q3 2025
    5.76
    Nine months 2026
    34.27
    Nine months 2025
    15.82
  • of which research and development
    Q3 2026
    4.21
    Q3 2025
    2.56
    Nine months 2026
    16.51
    Nine months 2025
    7.31
  • Operating profit (loss)
    Q3 2026
    (2.61)
    Q3 2025
    0.22
    Nine months 2026
    (12.47)
    Nine months 2025
    1.29
  • Net profit (loss)
    Q3 2026
    (2.09)
    Q3 2025
    0.92
    Nine months 2026
    (9.41)
    Nine months 2025
    2.29

Source: Robotis quarterly report (DART, Nov 16, 2026), consolidated statement of comprehensive income and note 23, converted from KRW. Gross margin is gross profit divided by revenue (MEKAWIRE calc.).

As of Nov 16, 2026

Selling and administrative expenses were KRW 34.27bn in the nine months, 2.2 times the KRW 15.82bn of a year earlier (MEKAWIRE calc.). Research and development charged to that line rose to KRW 16.51bn from KRW 7.31bn, according to note 23 to the consolidated statements, and the report puts research and development at 40.57% of revenue. In the third quarter alone selling and administrative expenses were KRW 9.69bn, against KRW 5.76bn a year earlier.

Gross margin moved the other way. It was 53.6% in the nine months against 62.6% a year earlier, and 52.6% in the third quarter against 64.8% (MEKAWIRE calc.). Operating activities used KRW 19.03bn of cash in the nine months, where they had generated KRW 6.06bn a year earlier, and inventories rose to KRW 27.93bn from KRW 13.60bn at the end of 2025.

Actuators are 98% of sales and 71% of sales are exports

Robotis sales by product and market, January to September 2026 (KRW bn)
  • Actuators
    Sales
    39.91
    Share of total
    98.1%
  • Autonomous driving robots
    Sales
    0.77
    Share of total
    1.9%
  • Total
    Sales
    40.68
    Share of total
    100%
  • Exports
    Sales
    28.84
    Share of total
    70.9%
  • Domestic
    Sales
    11.84
    Share of total
    29.1%

Source: Robotis quarterly report (DART, Nov 16, 2026), section II.4 (a), sales results: the segment totals and the export and domestic rows of the total line. Shares are MEKAWIRE calc.

As of Nov 16, 2026

The report describes Robotis as a company that builds the whole chain from actuators to humanoid platforms, naming the bipedal AI Sapiens and the semi-humanoid AI Worker. Its sales table in section II.4 has two lines only. Actuators brought in KRW 39.91bn in nine months and autonomous driving robots KRW 0.77bn, so actuators are 98.1% of the total (MEKAWIRE calc.). The same table gives exports of KRW 28.84bn, or 70.9% of the total, and domestic sales of KRW 11.84bn.

The spending is aimed at volume. Robotis said it is building a production base in Uzbekistan with a target of starting operation in the second quarter of 2027, and that it expects capacity of up to several million actuators a year once production there is stable; the report labels the timing and capacity as plans that may change. It said it resumed sales at its China branch in February 2026, plans to launch DYNAMIXEL-Q, a quasi-direct-drive actuator for humanoid joints, and has a medium-term vision of producing 10,000 AI Sapiens humanoids a year.

Two transactions changed the group. On July 15 Robotis took control of JST, a maker of production automation equipment in Gimhae, through an investment fund that bought 80.0% of JST. Robotis put KRW 18.1bn into the fund and its effective stake in JST is 50.28%; the stated reason is automation of actuator production. After the reporting period, on Nov 6, subsidiary Robotis AI issued 200,000 common shares to a third party, which changed the group's stake to 33.33%, according to note 36 on events after the reporting period.

MEKAWIRE analysis: spending like a humanoid company, earning like a parts maker

Robotis is paying for a humanoid future out of an actuator business, and the third quarter shows the cost without the one-off.

The balance sheet gives it time. The consolidated statement of financial position in the report shows cash and cash equivalents of KRW 70.88bn, short-term financial instruments of KRW 85.80bn and current financial assets at fair value through profit or loss of KRW 55.57bn at Sept 30, KRW 212.2bn in all (MEKAWIRE calc.), against total liabilities of KRW 19.98bn. At the nine-month rate of operating cash use, KRW 19.03bn, that is more than eight years (MEKAWIRE calc.).

The counter-argument is that orders have to follow. MEKAWIRE reported that Robotis said in a DART filing on Oct 28 that its signing with Pollen Robotics was not yet a supply contract and that no order had been placed. Other Korean robot makers that filed on Nov 16 and that MEKAWIRE has covered are CMES Robotics and Brils.

Three dates matter: the follow-up filing on Pollen Robotics that Robotis has said it will make by Nov 27, the annual report due by the end of March 2027, and the Uzbekistan start targeted for the second quarter of 2027.

Good or bad news for the company?

 

Key facts
R&D
KRW 16.51bn in nine months, 40.57% of revenue
Actuators
98.1% of sales, exports 70.9% (sales table, report section II.4)
Q3 revenue
KRW 13.47bn, up 45.8% from KRW 9.24bn
Share grant
KRW 11,781m of treasury shares to employees, Jan 26, 2026
Uzbekistan plant
Q2 2027 target for the start of operation
Nine-month revenue
KRW 40.68bn, above the KRW 38.94bn of all of 2025
Q3 operating result
KRW 2.61bn loss, against a KRW 224m profit
Nine-month operating loss
KRW 12.47bn, about KRW 0.69bn without the share grant (MEKAWIRE calc.)
Sources